Umbilical Cord Blood Transplantation to Treat

Pelizaeus-Merzbacher Disease (PMD) is a rare X-linked recessive leukodystrophy caused by mutations in the proteolipid protein 1 gene on the Xq22 chromosome. PMD is a dysmyelinating disorder characterized by variable clinical presentation and course. Symptoms range from mild motor deficits to progressive spasticity and neurologic decline resulting in death at an early age. There is no definitive curative treatment. This report presents the clinical course of 2 young boys with PMD who are the first known patients to receive umbilical cord blood transplantation as a therapeutic intervention to stabilize disease progression. Pretransplantation evaluation revealed that both patients had significant motor deficits as well as delayed cognitive function as compared with age-matched peers. Brain imaging revealed varying degrees of hypomyelination. Both patients received myeloablative chemotherapy followed by an unrelated donor umbilical cord blood infusion, which they tolerated well with no major transplantation-related complications. At 7-years and 1-year posttransplantation, respectively, both boys are making slow neurocognitive improvements and show no evidence of functional decline. Imaging results show stable or improving myelination. Although the results of unrelated donor umbilical cord blood transplantation in these 2 boys with PMD are encouraging, longerterm follow-up will be necessary to assess the effect of this treatment on the variable natural disease course. Pediatrics 2014;134:e1–e7 AUTHORS: Jessica Wishnew, MD,a Kristin Page, MD,a Susan Wood, MN, C-PNP,a Leo Galvin, MD,b James Provenzale, MD,b Maria Escolar, MD, MS,c Kathryn Gustafson, PhD,d and Joanne Kurtzberg, MDa aPediatric Blood and Marrow Transplant Program, bDivision of Neuroradiology, and dDepartment of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina; and cProgram for the Study of Neurodevelopment in Rare Disorders, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

[1]  P. Seeman,et al.  Three New PLP1 Splicing Mutations Demonstrate Pathogenic and Phenotypic Diversity of Pelizaeus-Merzbacher Disease , 2014, Journal of child neurology.

[2]  M. Poe,et al.  Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  R. Henry,et al.  Neural Stem Cell Engraftment and Myelination in the Human Brain , 2012, Science Translational Medicine.

[4]  J. Garbern,et al.  Pelizaeus-Merzbacher Disease, Pelizaeus-Merzbacher-Like Disease 1, and Related Hypomyelinating Disorders , 2012, Seminars in Neurology.

[5]  J. Golden,et al.  Neuronal loss in Pelizaeus–Merzbacher disease differs in various mutations of the proteolipid protein 1 , 2009, Acta Neuropathologica.

[6]  J. Kurtzberg,et al.  Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes. , 2008, Blood.

[7]  J. Kurtzberg,et al.  105: Augmentation of Standard Umbilical Cord Blood Transplantation with ALDHbr Cells: Results of a Phase I Study in Pediatric Patients , 2008 .

[8]  M. Poe,et al.  Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  J. Stockman,et al.  Transplantation of Umbilical-Cord Blood in Babies With Infantile Krabbe's Disease , 2007 .

[10]  K. Woodward,et al.  Three or more copies of the proteolipid protein gene PLP1 cause severe Pelizaeus-Merzbacher disease. , 2005, Brain : a journal of neurology.

[11]  Ken Inoue PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2 , 2005, Neurogenetics.

[12]  M. Poe,et al.  Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. , 2004, The New England journal of medicine.

[13]  B. Dastugue,et al.  Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations , 2000, European Journal of Human Genetics.

[14]  M. Shy,et al.  The molecular pathogenesis of Pelizaeus-Merzbacher disease. , 1999, Archives of neurology.

[15]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.